Clinical Trials on Contrast-induced Nephropathy in Austria

Total 329 results

Medical University of Graz
Abbott Diagnostics Division

Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy

Contrast Media Induced Nephropathy (CIN)

Austria
CardioRenal Systems, Inc.

Active, not recruiting

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients (CIN-RG)

Contrast Induced Nephropathy

United States
Osprey Medical, Inc

Completed

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN (AVERT™)

Contrast Induced Nephropathy (CIN)

United States, New Zealand, Australia
Vienna Hospital Association

Completed

High Tone Therapy for Chemotherapy Induced Neuropathy

Electrical Stimulation | Chemotherapy-induced Peripheral Neuropathy

Austria
Vienna Hospital Association

Recruiting

The Mamma HiToP Study

Chemotherapy-induced Peripheral Neuropathy

Austria
Medical University Innsbruck

Recruiting

Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy

Chemotherapeutic Toxicity | Chemotherapy-induced Peripheral Neuropathy | Chemotherapeutic Agent Toxicity

Austria
Medical University of Vienna

Completed

A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects

Visual Acuity | Lenses, Intraocular | Contrast Sensitivity

Austria
Sonnet BioTherapeutics

Terminated

SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Australia
Medical University of Vienna

Completed

MTF Image Modifications

Visual Acuity | Contrast Sensitivity | Modulation Transfer Function

Austria
Medical University of Graz

Completed

Pilot Study: Sectio Bonding/Early Skin-to-skin Contact (SSC) After Caesarean Section (SSC)

Early Skin-to-skin Contact

Austria
Clinuvel Pharmaceuticals Limited

Completed

Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)

Polymorphic Light Eruption (PLE)

Austria, Australia, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Chemotherapy-Induced Peripheral Neuropathy

Australia, Germany, Italy, Spain, Korea, Republic of, Taiwan
Medical University of Vienna

Unknown

Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection

Gd-based Contrast Media Exposure During Breast MRI Scans

Austria
Medical University of Vienna

Recruiting

High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study

Contact Lens | Tear Film Thickness

Austria
University of Milano Bicocca

Recruiting

International CIPN Assessment and Validation Study (ICAVS)

Quality of Life | Chemotherapy-induced Peripheral Neuropathy

United States, Italy, France, Australia, Austria, Bangladesh, Brazil, Canada, Denmark, Germany, Greece, Kenya, Korea, Republic of, Portugal, Spain, Switzerland
Medical University of Vienna

Completed

Retinal Neuro-vascular Coupling in Patients With Non-arteritic Anterior Ischemic Optic Neuropathy

Anterior Ischemic Optic Neuropathy

Austria
Medical University of Graz

Completed

Magnetic Resonance Imaging in the Diagnosis of Pulmonary Hypertension

Pulmonary Hypertension | Ventricular Function | MR Phase Contrast Velocity Imaging | Late Enhancement Patterns

Austria
Medical University of Graz

Completed

Calcipotriol and Polymorphic Light Eruption

Polymorphic Light Eruption

Austria
Medical University of Graz
Austrian Science Fund (FWF)

Terminated

Vitamin D Supplementation in Polymorphic Light Eruption (VitD-PLE_2012)

Polymorphic Light Eruption

Austria
Medical University of Graz

Completed

Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption

Polymorphic Light Eruption

Austria
Azura Ophthalmics
Avania

Completed

Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD)

Contact Lens Discomfort

Australia
Actinogen Medical
ICON plc

Completed

Xanamem™ in Healthy Elderly Subjects (XanaHES)

Cognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre Neuropathy

Australia
Medical University of Graz

Recruiting

Skin Microbiome and Polymorphic Light Eruption (PLE_microbio)

Polymorphic Light Eruption

Austria
Memo Therapeutics AG

Completed

Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers. (SAFE KIDNEY I)

BK Virus Nephropathy

Australia
Apeiron Biologics

Completed

Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer

Radiation Induced Dermatitis

Austria
Medical University of Vienna

Recruiting

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Heparin-induced Thrombocytopenia

Austria
The University of New South Wales

Completed

The Effect of Eyelid Margin Debridement on Contact Lens Discomfort

Contact Lens Discomfort

Australia
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Terminated

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Diabetic Nephropathy

Australia
Rigel Pharmaceuticals

Completed

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

IGA Nephropathy

United States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
Landeskrankenhaus Feldkirch

Completed

Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study

Diabetic Peripheral Neuropathy | Diabetes Mellitus Type I | Nerve Conduction Study Not Performed

Austria
The University of Queensland
University of Adelaide

Not yet recruiting

REmission in Membranous Nephropathy International Trial (REMIT) (REMIT)

Primary Membranous Nephropathy

Australia
Bayer

Completed

Primovist / Eovist in Renally Impaired Patients (PERI)

Contrast Media

United States, Germany, Italy, Korea, Republic of, Austria, Thailand, Australia, Spain, United Kingdom
argenx

Recruiting

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy (ARDA+)

Multifocal Motor Neuropathy (MMN)

United Kingdom, Spain, United States, Italy, Netherlands, Germany, France, Belgium, Canada, Poland, Austria
Medical University of Vienna

Completed

Effect of Breathing a Mixture of 92% Oxygen (O2) + 8% Carbon Dioxide (CO2) on Flicker Induced Blood Flow Changes in Ocular Perfusion

Flicker-induced Vasodilatation

Austria
Medical University of Vienna

Recruiting

Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

Gender Dysphoria | Hormone Therapy Induced Morphologic Change

Austria
Mesoblast, Ltd.

Completed

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

Diabetic Nephropathy | Type 2 Diabetes

Australia
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
Pfizer

Completed

CP-481,715 Nickel Allergy Study.

Dermatitis, Allergic Contact

United States, Denmark
Medical University of Graz

Recruiting

Pre-op Fluid Study

Anesthesia | Hypotension Drug-Induced

Austria
Ionis Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Canada, Australia, New Zealand, Singapore
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Terminated

Effect of Sulodexide in Overt Diabetic Nephropathy

Diabetic Nephropathy

United States, Australia, Netherlands
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

Effect of Sulodexide in Early Diabetic Nephropathy

Diabetic Nephropathy

United States, Australia, Netherlands
Prim PD Dr Afshin Assadian
Wilhelminenspital Vienna

Unknown

The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation (ILOFLOW)

Arteriosclerosis | Diabetes | Peripheral Arterial Occlusive Disease | Neuropathy

Austria
Azura Ophthalmics
The University of New South Wales

Completed

An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD)

Meibomian Gland Dysfunction (MGD) | Contact Lens Discomfort (CLD)

Australia
Medical University of Graz

Completed

Regulatory T Cells (Tregs) in Polymorphic Light Eruption

Psoriasis | Atopic Eczema | Polymorphic Light Eruption

Austria
Medical University of Graz

Completed

Alcohol and Innate Immunity

Binge Drinking

Austria
German Diabetes Center
Medical University of Vienna

Completed

Fat and Transcapillary Insulin Transport (FATRAIN)

Lipid-induced Insulin Resistance

Austria
Center of Integrative Addiction Research, Austria
Medical University of Graz

Unknown

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment of Substance Use Disorders

Substance Use Disorders | Psychotherapy

Austria
Indivior Inc.

Completed

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence

Austria
Medical University of Vienna

Unknown

Possible Effects of Energy Drink Ingestion on Perceived Alcohol Intoxication

Perceived Alcohol Intoxication

Austria

Clinical Trials on Contrast-induced Nephropathy in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations